The distinctive feature of the campaign was that it targeted Orange Book listings directly arguing that listing a non-qualifying patent violates the FTC Acts prohibition on unfair or deceptive practices rather than attacking downstream settlement agreements, as earlier enforcement actions had done
Jastreboff and colleagues reported a 48-week phase 2, randomized, double-blind, placebo-controlled trial in the New England Journal of Medicine in 2023
WARNING: If you are pregnant, nursing, taking any medications, including blood thinners, or have any medical condition, consult your doctor before use
Wang JS, Tu ST, Lee IT, et al
This is a convenient option for busy professionals, frequent travelers or anyone who prefers on site care
doi: 10.3389/fnins.2023.1047778 Received 18 September 2022 Accepted 13 February 2023 Published 24 February 2023 Volume 17 - 2023 Edited by Giuseppe Barisano, Stanford University, United States Reviewed by Mehmet Kaya, Ko University, Trkiye